GlobeImmune - Articles and news items

GS-4774

Top-line results announced for Phase 2 study of GS-4774 in patients with chronic hepatitis B

Industry news / 28 May 2015 / Victoria White

Top line results have been announced from the GS-4774 Phase 2 study in patients with HBV on long term viral suppression with an oral antiviral treatment…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+